MX5971E - Procedimiento para la preparacion de derivados del acido acil glutamico - Google Patents

Procedimiento para la preparacion de derivados del acido acil glutamico

Info

Publication number
MX5971E
MX5971E MX808946U MX894680U MX5971E MX 5971 E MX5971 E MX 5971E MX 808946 U MX808946 U MX 808946U MX 894680 U MX894680 U MX 894680U MX 5971 E MX5971 E MX 5971E
Authority
MX
Mexico
Prior art keywords
acid
derivatives
procedure
preparation
glutamic acid
Prior art date
Application number
MX808946U
Other languages
English (en)
Inventor
Yoshihiko Kitaura
Osamu Nakaguchi
Keiji Hemmi
Matsuhiko Aratani
Hidekazu Takeno
Satoshi Okada
Hirokazu Tanaka
Masashi Hashimoto
Yoshio Kuroda
Eiko Iguchi
Masanobu Kohsaka
Hatsuo Aoki
Hiroshi Imanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/093,523 external-priority patent/US4311640A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of MX5971E publication Critical patent/MX5971E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX808946U 1979-07-31 1980-07-30 Procedimiento para la preparacion de derivados del acido acil glutamico MX5971E (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB7926705 1979-07-31
GB7935401 1979-10-11
GB7935730 1979-10-15
GB7936000 1979-10-17
GB7937343 1979-10-29
US06/093,523 US4311640A (en) 1978-11-14 1979-11-13 Peptide, process for preparation thereof and use thereof
US11002080A 1980-01-07 1980-01-07
US14771080A 1980-05-08 1980-05-08
US14944180A 1980-05-13 1980-05-13

Publications (1)

Publication Number Publication Date
MX5971E true MX5971E (es) 1984-09-10

Family

ID=27576280

Family Applications (1)

Application Number Title Priority Date Filing Date
MX808946U MX5971E (es) 1979-07-31 1980-07-30 Procedimiento para la preparacion de derivados del acido acil glutamico

Country Status (8)

Country Link
EP (1) EP0025842B1 (es)
JP (2) JPS63258488A (es)
AU (1) AU544864B2 (es)
DE (1) DE3071977D1 (es)
DK (1) DK156252C (es)
GR (1) GR65931B (es)
HU (1) HU188565B (es)
MX (1) MX5971E (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539155A (en) * 1978-11-14 1985-09-03 Fuisawa Pharmaceutical Company, Ltd. New peptide, process for preparation thereof and use thereof
US4749691A (en) * 1978-11-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4458078A (en) * 1978-11-14 1984-07-03 Fujisawa Pharmaceutical Company, Ltd. Oxazole derivatives
US4801580A (en) * 1978-11-14 1989-01-31 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
IE51684B1 (en) * 1980-10-27 1987-02-04 Fujisawa Pharmaceutical Co Peptides,process for their preparation and pharmaceutical compositions containing them
GR81332B (es) * 1980-12-01 1984-12-11 Fujisawa Pharmaceutical Co
US4565653A (en) * 1984-03-30 1986-01-21 Pfizer Inc. Acyltripeptide immunostimulants
ATE46347T1 (de) * 1985-11-25 1989-09-15 Pfizer Immunostimulierende peptide.
FR2635779A2 (fr) * 1987-02-26 1990-03-02 Roussel Uclaf Nouveaux derives de l'acide glutamique, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2611721B1 (fr) * 1987-02-26 1990-01-26 Roussel Uclaf Nouveaux derives de l'acide glutamique, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4938956A (en) * 1987-04-01 1990-07-03 International Minerals & Chemical Corp. Synergistic immunostimulating composition and method
GB8806429D0 (en) * 1988-03-18 1988-04-20 Fujisawa Pharmaceutical Co Fr-900493 substance process for production & pharmaceutical composition containing same
FR2684674B1 (fr) * 1991-12-10 1994-01-28 Thevac Sarl Azapeptides et leur procede de preparation.
JP3001173U (ja) * 1994-02-18 1994-08-23 有限会社野々川商事 染毛用ブラシ
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2248025A2 (en) * 1973-10-23 1975-05-16 Anvar Vaccine compsns. - contg. N-acyl muramic acid deriv. as adjuvant
FR2292486A1 (fr) * 1974-07-01 1976-06-25 Anvar Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes
FR2324311A1 (fr) * 1975-09-17 1977-04-15 Anvar Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes
FR2343484A1 (fr) * 1976-03-10 1977-10-07 Anvar Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant
JPS52151732A (en) * 1976-06-14 1977-12-16 Kyowa Hakko Kogyo Co Ltd Prophylactic and therapeutic agent against bacterial
JPS52151731A (en) * 1976-06-14 1977-12-16 Kyowa Hakko Kogyo Co Ltd Tumor-inhibitory composition
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
JPS54130516A (en) * 1978-03-31 1979-10-09 Yuuichi Yamamura Acyllnnacetylmuramylpeptide derivativeeantigen combination
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
FR2460289A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent

Also Published As

Publication number Publication date
DK156252B (da) 1989-07-17
JPH02288895A (ja) 1990-11-28
JPH0327560B2 (es) 1991-04-16
HU188565B (en) 1986-04-28
JPH0613549B2 (ja) 1994-02-23
EP0025842B1 (en) 1987-06-03
AU544864B2 (en) 1985-06-20
JPS63258488A (ja) 1988-10-25
AU6093980A (en) 1981-03-19
EP0025842A2 (en) 1981-04-01
GR65931B (es) 1980-12-16
DE3071977D1 (en) 1987-07-09
DK156252C (da) 1989-12-18
EP0025842A3 (en) 1982-02-10
DK327280A (da) 1981-02-01

Similar Documents

Publication Publication Date Title
ES494590A0 (es) Procedimiento para la preparacion de derivados de acidos b- carbolin-3-carboxilicos
ES524495A0 (es) Procedimiento para la preparacion de derivados del acido metilendifosfonico
MX6094E (es) Procedimiento para preparar derivados del acido 6 beta-hidroxialquil penicilanico
MX5877E (es) Procedimiento para la preparacion de derivados del acido piridiloxifenoxi-alfa-propionico
MX5477E (es) Procedimiento para la preparacion de derivados de acido pseudomonico
ES494989A0 (es) Procedimiento para la preparacion de derivados de aminoaci- dos
ES488921A0 (es) Procedimiento para la preparacion de nuevos derivados 2- substituidos del acido 5-fenoxifenilfosfonico
MX5971E (es) Procedimiento para la preparacion de derivados del acido acil glutamico
MX5149E (es) Procedimiento mejorado para la preparacion de derivados de acido cicloalquilidenmetilfenilacetico
ES499856A0 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-azabiciclo (3-2-0) hept-2-en-2-carboxilico
ES533495A0 (es) Procedimiento para la preparacion de derivados del acido oxamidico
AR230056A1 (es) Procedimiento para la preparacion de derivados del acido 3-ridilmetilo 3-piridilmetilo 3-inidazolilmetil indolil-acrilico
AR221051A1 (es) Procedimiento para la preparacion de derivados del acido aminodesoxiclavulanico
AR223663A1 (es) Procedimiento para la preparacion de derivados 1,6-disustituidos de acido 4-piridon-3-carboxilico
MX6132E (es) Procedimiento para la preparacion de derivados de ester del acido ciclopropancarboxilico
ES538029A0 (es) Procedimiento para la preparacion de derivados del acido indolacetico
MX153817A (es) Procedimiento para la preparacion de acido 4,4'-dinitro-estilben-2,2-disulfonico
ES489186A0 (es) Un procedimiento para la preparacion de derivados del acido penicilamico 6-b-sustituidos.
ES490729A0 (es) Procedimiento para la preparacion de nuevas imidas de acido ciclobutandicarboxilico
ES523664A0 (es) Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico.
AR218060A1 (es) Procedimiento para la preparacion de derivados de acido 11-oxo-11h-pirido(2,1-b)quinazolina-2-carboxilico
ES491601A0 (es) Procedimiento para la preparacion de derivados de acido n-acil-amino
AR218294A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico
MX3745E (es) Procedimiento para la preparacion de acido 6,11-dihidro-11-oxodibenz-(b,e)oxepin-2-alcanoico
ES490959A0 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos